Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Tsukamoto

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 31, 2018
[Diagnostic (Classification) Criteria and Treatment Guidelines of Collagen-vascular Diseases: Hos to Use and Cautions on Applying Them for General Physicians. Topics: III. Dermatomyositis・Polymyositis]Hiroshi Tsukamoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 27, 2014
[Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: IV. Recent topics: 4. Hematopoietic stem cell transplantation for autoimmune diseases]Hiroshi Tsukamoto
Rinsho Byori. the Japanese Journal of Clinical Pathology|August 18, 2006
[Clinical aspects of the complement system]Hiroshi Tsukamoto, Takahiko Horiuchi
Inflammation and Regeneration|December 21, 2017
Complement-targeted therapy: development of C5- and C5a-targeted inhibitionTakahiko Horiuchi, Hiroshi Tsukamoto
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 24, 2009
Segmental evaluation of the peripheral nerve using tibial nerve SEPs for the diagnosis of CIDPHiroshi Tsukamoto, Masahiro Sonoo, Teruo Shimizu
Modern Rheumatology|July 18, 2012
Association of hepatitis B with antirheumatic drugs: a case-control studyYasuo Oshima, Hiroshi Tsukamoto, Arinobu Tojo
Journal of Biochemistry|August 4, 2007
Molecular cloning, expression and properties of an alpha/beta-Galactoside alpha2,3-sialyltransferase from Vibrio sp. JT-FAJ-16Yoshimitsu Takakura, Hiroshi Tsukamoto, Takeshi Yamamoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|January 10, 2014
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 5. Hepatic and gastrointestinal manifestations in collagen vascular diseases]Shinji Shimoda, Mitsuteru Akahoshi, Hiroshi Tsukamoto
The Journal of Biological Chemistry|August 19, 2007
Purification, cloning, and expression of an alpha/beta-galactoside alpha-2,3-sialyltransferase from a luminous marine bacterium, Photobacterium phosphoreumHiroshi Tsukamoto, Yoshimitsu Takakura, Takeshi Yamamoto
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 2, 2011
[Progress in classification and treatment for TNF receptor-associated periodic syndrome]Hiroshi Tsukamoto, Naoyasu Ueda, Takahiko Horiuchi
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 31, 2018
[Diagnostic (Classification) Criteria and Treatment Guidelines of Collagen-vascular Diseases: Hos to Use and Cautions on Applying Them for General Physicians. Topics: III. Dermatomyositis・Polymyositis]Hiroshi Tsukamoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 27, 2014
[Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: IV. Recent topics: 4. Hematopoietic stem cell transplantation for autoimmune diseases]Hiroshi Tsukamoto
Rinsho Byori. the Japanese Journal of Clinical Pathology|August 18, 2006
[Clinical aspects of the complement system]Hiroshi Tsukamoto, Takahiko Horiuchi
Inflammation and Regeneration|December 21, 2017
Complement-targeted therapy: development of C5- and C5a-targeted inhibitionTakahiko Horiuchi, Hiroshi Tsukamoto
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 24, 2009
Segmental evaluation of the peripheral nerve using tibial nerve SEPs for the diagnosis of CIDPHiroshi Tsukamoto, Masahiro Sonoo, Teruo Shimizu
Modern Rheumatology|July 18, 2012
Association of hepatitis B with antirheumatic drugs: a case-control studyYasuo Oshima, Hiroshi Tsukamoto, Arinobu Tojo
Journal of Biochemistry|August 4, 2007
Molecular cloning, expression and properties of an alpha/beta-Galactoside alpha2,3-sialyltransferase from Vibrio sp. JT-FAJ-16Yoshimitsu Takakura, Hiroshi Tsukamoto, Takeshi Yamamoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|January 10, 2014
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 5. Hepatic and gastrointestinal manifestations in collagen vascular diseases]Shinji Shimoda, Mitsuteru Akahoshi, Hiroshi Tsukamoto
The Journal of Biological Chemistry|August 19, 2007
Purification, cloning, and expression of an alpha/beta-galactoside alpha-2,3-sialyltransferase from a luminous marine bacterium, Photobacterium phosphoreumHiroshi Tsukamoto, Yoshimitsu Takakura, Takeshi Yamamoto
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 2, 2011
[Progress in classification and treatment for TNF receptor-associated periodic syndrome]Hiroshi Tsukamoto, Naoyasu Ueda, Takahiko Horiuchi
Pageof 11